Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
Service Properties Trust $1 billion senior secured notes offering
We advised SVC on its high-yield secured notes offering
Amneal Pharmaceuticals $2.35 billion term loan
We advised Amneal Pharmaceuticals on a new term loan
Banco Santander $3.75 billion senior preferred notes
We advised Banco Santander on its investment-grade debt offering
Williams acquisitions of Cureton and Rocky Mountain Midstream
We are advising Williams on the acquisitions
Canadian National Railway $600 million notes offering
We advised Canadian National Railway on the offering
Morgan Stanley $4 billion senior notes offering
We advised Morgan Stanley on its SEC-registered global offering
Morgan Stanley Bank $2 billion senior notes offering
We advised Morgan Stanley Bank on its 3(a)(2) notes offering
DXC Technology $230 million revolving facility increase
We advised the borrower on the financing
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
GSK collaboration extension and new data licensing agreement with 23andMe
We advised GSK on the transaction